This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
CUY | PIRSA Go-ahead for Oban field trial | PRICE SENSITIVE | 26/03/09 | |
CUY | Half Yearly Accounts | 20/03/09 | ||
CUY | Quarterly Activities and Cashflow Reports | PRICE SENSITIVE | 27/02/09 | |
CUY | Competent Person Statement | 23/01/09 | ||
CUY | Results of AGM and Chairmans Address | 09/12/08 | ||
CUY | Key Permitting Document Lodged With PIRSA | PRICE SENSITIVE | 08/12/08 | |
CUY | Quarterly Activities Report and Cashflow Report | PRICE SENSITIVE | 28/11/08 | |
CUYPIRSA Go-ahead for Oban field trial | |||
26/03/09 | PRICE SENSITIVE | ||
CUYHalf Yearly Accounts | |||
20/03/09 | |||
CUYQuarterly Activities and Cashflow Reports | |||
27/02/09 | PRICE SENSITIVE | ||
CUYCompetent Person Statement | |||
23/01/09 | |||
CUYResults of AGM and Chairmans Address | |||
09/12/08 | |||
CUYKey Permitting Document Lodged With PIRSA | |||
08/12/08 | PRICE SENSITIVE | ||
CUYQuarterly Activities Report and Cashflow Report | |||
28/11/08 | PRICE SENSITIVE | ||